NOT KNOWN FACTUAL STATEMENTS ABOUT SR9009

Cure with SR18662 substantially decreases expansion and proliferation of CRC cells. SR18662 exhibits enhanced efficacy in decreasing viability of various CRC cell traces. Move cytometry Examination next SR18662 therapy demonstrates an increase in cells captured in possibly S or G2/M phases of the cell cycle and an important rise in the volume of ap